Cost effectiveness of spread mitigation strategies for polyphagous shot hole borer (Coleoptera: Curculionidae: Scolytinae).

Polyphagous shot hole borer Eichhoff was detected in Western Australia in September 2021, and an eradication campaign funded by the Commonwealth government is underway. As part of contingency planning, we examined the cost effectiveness of alternative control strategies that could be used to mitigate urban forest impacts and maintain the benefits of trees to the local communities if eradication was not feasible. At the time this work was undertaken, decision-makers were concerned about the potential need to replace all urban trees susceptible to attack.

What Will Fall Armyworm (Lepidoptera: Noctuidae) Cost Western Australian Agriculture?

Following the detection of fall armyworm Spodoptera frugiperda (J.E. Smith, Lepidoptera: Noctuidae) in Western Australia in early 2020 and the lack of government response action, we estimate the impact it is likely to have on the state's agriculture.

Cost-consequence analysis of F-fluciclovine for the staging of recurrent prostate cancer.

: Current detection methodologies are often unable to identify the location and extent of recurrent prostate cancer (PCa) leading potentially to 'futile' local therapies in the presence of metastatic disease. The use of  F-fluciclovine PET/CT may lead to better patient management. : The aim of this study was to quantify the economic impact and cost-consequence of using  F-fluciclovine PET/CT in PCa recurrence.

Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.

Purpose: F-fluciclovine is a synthetic amino acid radiotracer that has recently been approved in Europe and the United States for PET imaging in men with biochemical recurrence (BCR) of prostate cancer after prior definitive treatment. Accurate identification of the sites of disease in patients presenting with BCR of prostate cancer is important in determining the appropriate treatment. Bone is the most frequent site of metastatic disease in patients with prostate cancer.

Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure.

Background: Galectin-3 is a carbohydrate binding protein that plays many important regulatory roles in inflammation, immunity and cancer. Recent studies indicate that galectin-3 is a mediator of heart failure development and progression. Development of an improved assay for galectin-3 measurement was necessary for appropriate clinical assessment.